Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Remicade (infliximab) Drug Market 2018, Forecast to 2023
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
Scope of the Report:
This report focuses on the Remicade (infliximab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Remicade (infliximab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Remicade (infliximab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Remicade (infliximab) Drug, with sales, revenue, and price of Remicade (infliximab) Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Remicade (infliximab) Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Remicade (infliximab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Remicade (infliximab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Remicade (infliximab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Remicade (infliximab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Janssen
- Hospira
- Celltrion Healthcare
- Epirus Biopharmaceuticals
- Samsung Bioepsis
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Brands Drugs
- Generic Drugs
- Crohn's Disease
- Pediatric Crohn's Disease
- Ulcerative Colitis
- Pediatric Ulcerative Colitis
- Other
Chapter 1, to describe Remicade (infliximab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Remicade (infliximab) Drug, with sales, revenue, and price of Remicade (infliximab) Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Remicade (infliximab) Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Remicade (infliximab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Remicade (infliximab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Remicade (infliximab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Brands Drugs
1.2.2 Generic Drugs
1.3 Market Analysis by Applications
1.3.1 Crohn's Disease
1.3.2 Pediatric Crohn's Disease
1.3.3 Ulcerative Colitis
1.3.4 Pediatric Ulcerative Colitis
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Janssen
2.1.1 Business Overview
2.1.1.1 Janssen Description
2.1.1.2 Janssen Headquarter, Main Business and Finance Overview
2.1.2 Janssen Remicade (infliximab) Drug Product Introduction
2.1.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Remicade (infliximab) Drug Product Information
2.1.3 Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Janssen Remicade (infliximab) Drug Market Share in 2017
2.2 Hospira
2.2.1 Business Overview
2.2.1.1 Hospira Description
2.2.1.2 Hospira Headquarter, Main Business and Finance Overview
2.2.2 Hospira Remicade (infliximab) Drug Product Introduction
2.2.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Remicade (infliximab) Drug Product Information
2.2.3 Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Hospira Remicade (infliximab) Drug Market Share in 2017
2.3 Celltrion Healthcare
2.3.1 Business Overview
2.3.1.1 Celltrion Healthcare Description
2.3.1.2 Celltrion Healthcare Headquarter, Main Business and Finance Overview
2.3.2 Celltrion Healthcare Remicade (infliximab) Drug Product Introduction
2.3.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.3.2.2 Remicade (infliximab) Drug Product Information
2.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Celltrion Healthcare Remicade (infliximab) Drug Market Share in 2017
2.4 Epirus Biopharmaceuticals
2.4.1 Business Overview
2.4.1.1 Epirus Biopharmaceuticals Description
2.4.1.2 Epirus Biopharmaceuticals Headquarter, Main Business and Finance Overview
2.4.2 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Introduction
2.4.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.4.2.2 Remicade (infliximab) Drug Product Information
2.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Epirus Biopharmaceuticals Remicade (infliximab) Drug Market Share in 2017
2.5 Samsung Bioepsis
2.5.1 Business Overview
2.5.1.1 Samsung Bioepsis Description
2.5.1.2 Samsung Bioepsis Headquarter, Main Business and Finance Overview
2.5.2 Samsung Bioepsis Remicade (infliximab) Drug Product Introduction
2.5.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.5.2.2 Remicade (infliximab) Drug Product Information
2.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Samsung Bioepsis Remicade (infliximab) Drug Market Share in 2017
3 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET COMPETITION, BY MANUFACTURER
3.1 Global Remicade (infliximab) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Remicade (infliximab) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Remicade (infliximab) Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Remicade (infliximab) Drug Manufacturer Market Share in 2017
3.4.2 Top 5 Remicade (infliximab) Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET ANALYSIS BY REGIONS
4.1 Global Remicade (infliximab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Remicade (infliximab) Drug Sales by Regions (2013-2018)
4.1.2 Global Remicade (infliximab) Drug Revenue by Regions (2013-2018)
4.2 North America Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Remicade (infliximab) Drug Sales by Countries (2013-2018)
5.1.2 North America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
5.1.3 United States Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.1.4 Canada Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.1.5 Mexico Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.2 North America Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
5.2.2 North America Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
5.3 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
5.3.2 North America Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
5.4.2 North America Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
6 EUROPE REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Remicade (infliximab) Drug Sales by Countries (2013-2018)
6.1.2 Europe Remicade (infliximab) Drug Revenue by Countries (2013-2018)
6.1.3 Germany Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.4 UK Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.5 France Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.6 Russia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.7 Italy Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.2 Europe Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
6.2.2 Europe Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Remicade (infliximab) Drug Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Remicade (infliximab) Drug Revenue by Countries (2013-2018)
7.1.3 China Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.4 Japan Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.5 Korea Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.6 India Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Remicade (infliximab) Drug Sales by Countries (2013-2018)
8.1.2 South America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
8.1.3 Brazil Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.1.4 Argentina Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.1.5 Colombia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.2 South America Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
8.2.2 South America Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
8.3 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
8.3.2 South America Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
8.4.2 South America Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Remicade (infliximab) Drug Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.4 UAE Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.5 Egypt Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.7 South Africa Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET SEGMENT BY TYPE
10.1 Global Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Remicade (infliximab) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Remicade (infliximab) Drug Revenue and Market Share by Type (2013-2018)
10.2 Brands Drugs Sales Growth and Price
10.2.1 Global Brands Drugs Sales Growth (2013-2018)
10.2.2 Global Brands Drugs Price (2013-2018)
10.3 Generic Drugs Sales Growth and Price
10.3.1 Global Generic Drugs Sales Growth (2013-2018)
10.3.2 Global Generic Drugs Price (2013-2018)
11 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET SEGMENT BY APPLICATION
11.1 Global Remicade (infliximab) Drug Sales Market Share by Application (2013-2018)
11.2 Crohn's Disease Sales Growth (2013-2018)
11.3 Pediatric Crohn's Disease Sales Growth (2013-2018)
11.4 Ulcerative Colitis Sales Growth (2013-2018)
11.5 Pediatric Ulcerative Colitis Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 REMICADE (INFLIXIMAB) DRUG MARKET FORECAST (2018-2023)
12.1 Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Remicade (infliximab) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.2 Europe Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.4 South America Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Remicade (infliximab) Drug Market Forecast (2018-2023)
12.3 Remicade (infliximab) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Remicade (infliximab) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Remicade (infliximab) Drug Market Share Forecast by Type (2018-2023)
12.4 Remicade (infliximab) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Remicade (infliximab) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Remicade (infliximab) Drug Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Remicade (infliximab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Brands Drugs
1.2.2 Generic Drugs
1.3 Market Analysis by Applications
1.3.1 Crohn's Disease
1.3.2 Pediatric Crohn's Disease
1.3.3 Ulcerative Colitis
1.3.4 Pediatric Ulcerative Colitis
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Janssen
2.1.1 Business Overview
2.1.1.1 Janssen Description
2.1.1.2 Janssen Headquarter, Main Business and Finance Overview
2.1.2 Janssen Remicade (infliximab) Drug Product Introduction
2.1.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Remicade (infliximab) Drug Product Information
2.1.3 Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Janssen Remicade (infliximab) Drug Market Share in 2017
2.2 Hospira
2.2.1 Business Overview
2.2.1.1 Hospira Description
2.2.1.2 Hospira Headquarter, Main Business and Finance Overview
2.2.2 Hospira Remicade (infliximab) Drug Product Introduction
2.2.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Remicade (infliximab) Drug Product Information
2.2.3 Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Hospira Remicade (infliximab) Drug Market Share in 2017
2.3 Celltrion Healthcare
2.3.1 Business Overview
2.3.1.1 Celltrion Healthcare Description
2.3.1.2 Celltrion Healthcare Headquarter, Main Business and Finance Overview
2.3.2 Celltrion Healthcare Remicade (infliximab) Drug Product Introduction
2.3.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.3.2.2 Remicade (infliximab) Drug Product Information
2.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Celltrion Healthcare Remicade (infliximab) Drug Market Share in 2017
2.4 Epirus Biopharmaceuticals
2.4.1 Business Overview
2.4.1.1 Epirus Biopharmaceuticals Description
2.4.1.2 Epirus Biopharmaceuticals Headquarter, Main Business and Finance Overview
2.4.2 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Introduction
2.4.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.4.2.2 Remicade (infliximab) Drug Product Information
2.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Epirus Biopharmaceuticals Remicade (infliximab) Drug Market Share in 2017
2.5 Samsung Bioepsis
2.5.1 Business Overview
2.5.1.1 Samsung Bioepsis Description
2.5.1.2 Samsung Bioepsis Headquarter, Main Business and Finance Overview
2.5.2 Samsung Bioepsis Remicade (infliximab) Drug Product Introduction
2.5.2.1 Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
2.5.2.2 Remicade (infliximab) Drug Product Information
2.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Samsung Bioepsis Remicade (infliximab) Drug Market Share in 2017
3 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET COMPETITION, BY MANUFACTURER
3.1 Global Remicade (infliximab) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Remicade (infliximab) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Remicade (infliximab) Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Remicade (infliximab) Drug Manufacturer Market Share in 2017
3.4.2 Top 5 Remicade (infliximab) Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET ANALYSIS BY REGIONS
4.1 Global Remicade (infliximab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Remicade (infliximab) Drug Sales by Regions (2013-2018)
4.1.2 Global Remicade (infliximab) Drug Revenue by Regions (2013-2018)
4.2 North America Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Remicade (infliximab) Drug Sales by Countries (2013-2018)
5.1.2 North America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
5.1.3 United States Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.1.4 Canada Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.1.5 Mexico Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
5.2 North America Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
5.2.2 North America Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
5.3 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
5.3.2 North America Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
5.4.2 North America Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
6 EUROPE REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Remicade (infliximab) Drug Sales by Countries (2013-2018)
6.1.2 Europe Remicade (infliximab) Drug Revenue by Countries (2013-2018)
6.1.3 Germany Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.4 UK Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.5 France Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.6 Russia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.1.7 Italy Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
6.2 Europe Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
6.2.2 Europe Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Remicade (infliximab) Drug Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Remicade (infliximab) Drug Revenue by Countries (2013-2018)
7.1.3 China Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.4 Japan Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.5 Korea Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.6 India Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Remicade (infliximab) Drug Sales by Countries (2013-2018)
8.1.2 South America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
8.1.3 Brazil Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.1.4 Argentina Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.1.5 Colombia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
8.2 South America Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
8.2.2 South America Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
8.3 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
8.3.2 South America Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
8.4.2 South America Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA REMICADE (INFLIXIMAB) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Remicade (infliximab) Drug Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.4 UAE Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.5 Egypt Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.1.7 South Africa Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Remicade (infliximab) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Remicade (infliximab) Drug Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Remicade (infliximab) Drug Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Remicade (infliximab) Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Remicade (infliximab) Drug Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Remicade (infliximab) Drug Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET SEGMENT BY TYPE
10.1 Global Remicade (infliximab) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Remicade (infliximab) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Remicade (infliximab) Drug Revenue and Market Share by Type (2013-2018)
10.2 Brands Drugs Sales Growth and Price
10.2.1 Global Brands Drugs Sales Growth (2013-2018)
10.2.2 Global Brands Drugs Price (2013-2018)
10.3 Generic Drugs Sales Growth and Price
10.3.1 Global Generic Drugs Sales Growth (2013-2018)
10.3.2 Global Generic Drugs Price (2013-2018)
11 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET SEGMENT BY APPLICATION
11.1 Global Remicade (infliximab) Drug Sales Market Share by Application (2013-2018)
11.2 Crohn's Disease Sales Growth (2013-2018)
11.3 Pediatric Crohn's Disease Sales Growth (2013-2018)
11.4 Ulcerative Colitis Sales Growth (2013-2018)
11.5 Pediatric Ulcerative Colitis Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 REMICADE (INFLIXIMAB) DRUG MARKET FORECAST (2018-2023)
12.1 Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Remicade (infliximab) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.2 Europe Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.4 South America Remicade (infliximab) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Remicade (infliximab) Drug Market Forecast (2018-2023)
12.3 Remicade (infliximab) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Remicade (infliximab) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Remicade (infliximab) Drug Market Share Forecast by Type (2018-2023)
12.4 Remicade (infliximab) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Remicade (infliximab) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Remicade (infliximab) Drug Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Remicade (infliximab) Drug Picture
Table Product Specifications of Remicade (infliximab) Drug
Figure Global Remicade (infliximab) Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Remicade (infliximab) Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Remicade (infliximab) Drug by Types in 2017
Figure Brands Drugs Picture
Table Major Manufacturers of Brands Drugs
Figure Generic Drugs Picture
Table Major Manufacturers of Generic Drugs
Figure Remicade (infliximab) Drug Sales Market Share by Applications in 2017
Figure Crohn's Disease Picture
Figure Pediatric Crohn's Disease Picture
Figure Ulcerative Colitis Picture
Figure Pediatric Ulcerative Colitis Picture
Figure Other Picture
Figure United States Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Table Janssen Headquarter, Established, Main Business and Finance Overview (2017)
Table Janssen Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Janssen Remicade (infliximab) Drug Product
Table Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Janssen Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Janssen Remicade (infliximab) Drug Revenue Market Share in 2017
Table Hospira Headquarter, Established, Main Business and Finance Overview (2017)
Table Hospira Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Hospira Remicade (infliximab) Drug Product
Table Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hospira Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Hospira Remicade (infliximab) Drug Revenue Market Share in 2017
Table Celltrion Healthcare Headquarter, Established, Main Business and Finance Overview (2017)
Table Celltrion Healthcare Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Celltrion Healthcare Remicade (infliximab) Drug Product
Table Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celltrion Healthcare Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Celltrion Healthcare Remicade (infliximab) Drug Revenue Market Share in 2017
Table Epirus Biopharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Product
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Epirus Biopharmaceuticals Remicade (infliximab) Drug Revenue Market Share in 2017
Table Samsung Bioepsis Headquarter, Established, Main Business and Finance Overview (2017)
Table Samsung Bioepsis Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Samsung Bioepsis Remicade (infliximab) Drug Product
Table Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Samsung Bioepsis Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Samsung Bioepsis Remicade (infliximab) Drug Revenue Market Share in 2017
Table Global Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Global Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Global Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Global Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Global Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Global Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Global Remicade (infliximab) Drug Price by Manufacturer (2016-2017)
Figure Top 3 Remicade (infliximab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Remicade (infliximab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Regions (2013-2018)
Table Global Remicade (infliximab) Drug Sales Market Share by Regions (2013-2018)
Table Global Remicade (infliximab) Drug Revenue by Regions (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue Market Share by Regions in 2013
Figure Global Remicade (infliximab) Drug Revenue Market Share by Regions in 2017
Figure North America Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure North America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure Europe Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure South America Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure South America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure North America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table North America Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table North America Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure North America Remicade (infliximab) Drug Sales Market Share by Countries in 2013
Figure North America Remicade (infliximab) Drug Sales Market Share by Countries in 2017
Table North America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Table North America Remicade (infliximab) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Remicade (infliximab) Drug Revenue Market Share by Countries in 2013
Figure North America Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure United States Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Canada Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Mexico Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table North America Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure North America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure North America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table North America Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure North America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure North America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table North America Remicade (infliximab) Drug Sales by Type (2013-2018)
Table North America Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table North America Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table North America Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table North America Remicade (infliximab) Drug Sales by Application (2013-2018)
Table North America Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table North America Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table North America Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Europe Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Countries in 2016
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure Germany Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure UK Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure France Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Russia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Italy Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table Europe Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Europe Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Europe Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Europe Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Europe Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Countries 2017
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Countries 2017
Figure China Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Japan Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Korea Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure India Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure South America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table South America Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table South America Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure South America Remicade (infliximab) Drug Sales Market Share by Countries in 2017
Table South America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Table South America Remicade (infliximab) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure Brazil Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Argentina Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Colombia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table South America Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure South America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure South America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table South America Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure South America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure South America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table South America Remicade (infliximab) Drug Sales by Type (2013-2018)
Table South America Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table South America Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table South America Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table South America Remicade (infliximab) Drug Sales by Application (2013-2018)
Table South America Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table South America Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table South America Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure UAE Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Egypt Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure South Africa Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Figure Global Brands Drugs Sales Growth (2013-2018)
Figure Global Brands Drugs Price (2013-2018)
Figure Global Generic Drugs Sales Growth (2013-2018)
Figure Global Generic Drugs Price (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Figure Global Crohn's Disease Sales Growth (2013-2018)
Figure Global Pediatric Crohn's Disease Sales Growth (2013-2018)
Figure Global Ulcerative Colitis Sales Growth (2013-2018)
Figure Global Pediatric Ulcerative Colitis Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Remicade (infliximab) Drug Sales Forecast by Regions (2018-2023)
Table Global Remicade (infliximab) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure Europe Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure South America Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Table Global Remicade (infliximab) Drug Sales Forecast by Type (2018-2023)
Table Global Remicade (infliximab) Drug Market Share Forecast by Type (2018-2023)
Table Global Remicade (infliximab) Drug Sales Forecast by Application (2018-2023)
Table Global Remicade (infliximab) Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Remicade (infliximab) Drug Picture
Table Product Specifications of Remicade (infliximab) Drug
Figure Global Remicade (infliximab) Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Remicade (infliximab) Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Remicade (infliximab) Drug by Types in 2017
Figure Brands Drugs Picture
Table Major Manufacturers of Brands Drugs
Figure Generic Drugs Picture
Table Major Manufacturers of Generic Drugs
Figure Remicade (infliximab) Drug Sales Market Share by Applications in 2017
Figure Crohn's Disease Picture
Figure Pediatric Crohn's Disease Picture
Figure Ulcerative Colitis Picture
Figure Pediatric Ulcerative Colitis Picture
Figure Other Picture
Figure United States Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2013-2023)
Table Janssen Headquarter, Established, Main Business and Finance Overview (2017)
Table Janssen Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Janssen Remicade (infliximab) Drug Product
Table Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Janssen Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Janssen Remicade (infliximab) Drug Revenue Market Share in 2017
Table Hospira Headquarter, Established, Main Business and Finance Overview (2017)
Table Hospira Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Hospira Remicade (infliximab) Drug Product
Table Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hospira Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Hospira Remicade (infliximab) Drug Revenue Market Share in 2017
Table Celltrion Healthcare Headquarter, Established, Main Business and Finance Overview (2017)
Table Celltrion Healthcare Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Celltrion Healthcare Remicade (infliximab) Drug Product
Table Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celltrion Healthcare Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Celltrion Healthcare Remicade (infliximab) Drug Revenue Market Share in 2017
Table Epirus Biopharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Product
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Epirus Biopharmaceuticals Remicade (infliximab) Drug Revenue Market Share in 2017
Table Samsung Bioepsis Headquarter, Established, Main Business and Finance Overview (2017)
Table Samsung Bioepsis Remicade (infliximab) Drug Production Bases, Sales Regions and Major Competitors
Table Samsung Bioepsis Remicade (infliximab) Drug Product
Table Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Samsung Bioepsis Remicade (infliximab) Drug Sales Market Share in 2017
Figure Global Samsung Bioepsis Remicade (infliximab) Drug Revenue Market Share in 2017
Table Global Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Global Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Global Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Global Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Global Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Global Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Global Remicade (infliximab) Drug Price by Manufacturer (2016-2017)
Figure Top 3 Remicade (infliximab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Remicade (infliximab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Regions (2013-2018)
Table Global Remicade (infliximab) Drug Sales Market Share by Regions (2013-2018)
Table Global Remicade (infliximab) Drug Revenue by Regions (2013-2018)
Figure Global Remicade (infliximab) Drug Revenue Market Share by Regions in 2013
Figure Global Remicade (infliximab) Drug Revenue Market Share by Regions in 2017
Figure North America Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure North America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure Europe Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure South America Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure South America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Figure North America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table North America Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table North America Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure North America Remicade (infliximab) Drug Sales Market Share by Countries in 2013
Figure North America Remicade (infliximab) Drug Sales Market Share by Countries in 2017
Table North America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Table North America Remicade (infliximab) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Remicade (infliximab) Drug Revenue Market Share by Countries in 2013
Figure North America Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure United States Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Canada Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Mexico Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table North America Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure North America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure North America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table North America Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure North America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure North America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table North America Remicade (infliximab) Drug Sales by Type (2013-2018)
Table North America Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table North America Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table North America Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table North America Remicade (infliximab) Drug Sales by Application (2013-2018)
Table North America Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table North America Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table North America Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Europe Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Countries in 2016
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure Germany Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure UK Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure France Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Russia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Italy Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table Europe Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Europe Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Europe Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Europe Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Europe Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table Europe Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table Europe Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Countries 2017
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Countries 2017
Figure China Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Japan Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Korea Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure India Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table Asia-Pacific Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure South America Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table South America Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table South America Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure South America Remicade (infliximab) Drug Sales Market Share by Countries in 2017
Table South America Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Table South America Remicade (infliximab) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure Brazil Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Argentina Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Colombia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table South America Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure South America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure South America Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table South America Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure South America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure South America Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table South America Remicade (infliximab) Drug Sales by Type (2013-2018)
Table South America Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table South America Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table South America Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table South America Remicade (infliximab) Drug Sales by Application (2013-2018)
Table South America Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table South America Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table South America Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales by Countries (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure UAE Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Egypt Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Figure South Africa Remicade (infliximab) Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue by Application (2013-2018)
Table Middle East and Africa Remicade (infliximab) Drug Revenue Share by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Type (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue Share by Type (2013-2018)
Figure Global Brands Drugs Sales Growth (2013-2018)
Figure Global Brands Drugs Price (2013-2018)
Figure Global Generic Drugs Sales Growth (2013-2018)
Figure Global Generic Drugs Price (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sales Share by Application (2013-2018)
Figure Global Crohn's Disease Sales Growth (2013-2018)
Figure Global Pediatric Crohn's Disease Sales Growth (2013-2018)
Figure Global Ulcerative Colitis Sales Growth (2013-2018)
Figure Global Pediatric Ulcerative Colitis Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Remicade (infliximab) Drug Sales Forecast by Regions (2018-2023)
Table Global Remicade (infliximab) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure Europe Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure South America Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Remicade (infliximab) Drug Market Forecast (2018-2023)
Table Global Remicade (infliximab) Drug Sales Forecast by Type (2018-2023)
Table Global Remicade (infliximab) Drug Market Share Forecast by Type (2018-2023)
Table Global Remicade (infliximab) Drug Sales Forecast by Application (2018-2023)
Table Global Remicade (infliximab) Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
